Investor Relation Menu

• IR Home
• Corporate Info
  • Chairman's Statement
  • Values and Brand Promise
  • Board Of Directors
  • Key Management
• Our Business Units
• Financial Info
  • Financials
  • Annual Reports
  • Sustainability Report
• Newsroom
  • Announcements
  • Press Releases
• Stock Info
• Info Request
  • Email Alerts
  • IR Contact

News

Change - Announcement Of Resignation Of Chief Executive Officer

BackJan 15, 2015

Announcement Title	Change - Announcement of Cessation
Announcement Subtitle	Resignation of Chief Executive Officer
Securities	ASIAMEDIC LIMITED (ASIAMED)
Date & Time of Broadcast	Jan 15, 2015 17:36
Submitted By	Stanley Woo Group Financial Controller
Description	This announcement has been prepared by the Company and reviewed by the Company's sponsor, Xandar Capital Pte Ltd (the "Sponsor"), for compliance with the Listing Manual (Section B: Rules of Catalist) of the Singapore Exchange Securities Trading Limited (the "SGX-ST"). The Sponsor has not independently verified the contents of this announcement including the accuracy or completeness of any of the information disclosed or the correctness of any of the statements made, opinions expressed or reports contained in this announcement. This announcement has not been examined or approved by the SGX-ST. The SGX-ST and the Sponsor assume no responsibility for the contents of this announcement including the correctness of any of the statements made, opinions expressed or reports contained in this announcement. Contact person for the Sponsor: Ms Pauline Sim (Registered Professional, Xandar Capital Pte Ltd) Address: 22 Cross Street, #03-54/61 China Square Central, Singapore 048421 Telephone number: (65) 6319 4954
Cessation Details
Name of person	Dr Wong Weng Hong
Age	51
Is effective date of cessation known?	Yes
Effective date for cessation	Jan 31, 2015
Detailed reason(s) for cessation	To pursue personal and professional interests.
Are there any unresolved differences in opinion on material matters between the person and the board of directors, including matters which would have a material impact on the group or its financial reporting?	No
Is there any matter in relation to the cessation that needs to be brought to the attention of the shareholders of the listed issuer?	No
Any other relevant information to be provided to shareholders of the listed issuer?	No
Date of appointment to current position	Mar 1, 2012
Does the AC have a minimum of 3 members (taking into account this cessation)?	Yes
Number of independent directors currently resident in Singapore (taking this account this cessation)	3
Number of cessations of appointments specified in Listing Rule 704(7) or Catalist Rule 704(6) over the past 12 months	0
Job Title	Chief Executive Officer
Role and responsibilities	Role of Chief Executive Officer reporting to the Board of Directors. Responsible for carrying out the strategies and policies as established by the Board and for the overall management, development and financial performance of the Group.
Familial relationship with any director and/or substantial shareholder of the listed issuer or of any of its principal subsidaries	No
Shareholdings interest in the listed issuer and its subsidaries?	Yes
Shareholding Details	No. of ordinary voting shares in AsiaMedic Limited: Direct interest: 62,000 Deemed interest: 14,604,000 Total: 14,666,000
Other directorships
Past (for the last 5 years)	Please refer to the attachment.
Present	Please refer to the attachment.

Attachments

1. Attachment 1 (Size: 4,158 bytes)